Clinical Trials

NCT07712874 | NOT_YET_RECRUITING
10000 participants

Screening Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-11
Start Date:
2026-08-16
Completion:
2050-07-02
Conditions
  • Pain
No Results Yet
NCT07703436 | NOT_YET_RECRUITING | PHASE2
40 participants

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2027-03-31
Completion:
2030-09-30
Conditions
  • Grade 2 IDH1-mutant Glioma
  • Grade 3 IDH1-mutant Glioma
  • Glioma
  • IDH1-mutant Glioma
  • Oligodendroglioma
  • Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted
  • Astrocytoma IDH Mutant Grade 3
  • Astrocytoma IDH Mutant Grade 2
Interventions
  • DRUG
No Results Yet
NCT07667400 | NOT_YET_RECRUITING | PHASE1/PHASE2
120 participants

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2026-08-16
Completion:
2036-10-01
Conditions
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Paranasal Sinus Neoplasms
  • Nasopharyngeal Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • Hypopharyngeal Cancer
  • Carcinoma of Larynx
  • Oral Squamous Cell Carcinoma
  • Salivary Gland Cancer
  • Adenoid Cystic Carcinoma
  • Prostate Cancer
  • Metastatic Castration Resistant Prostate Cancer
Interventions
  • DRUG
No Results Yet
NCT07657104 | NOT_YET_RECRUITING | NA
100 participants

Developing and Implementing HPV SCREENED

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2026-08-20
Completion:
2027-06-30
Conditions
  • Cervical Cancer Screening
  • Human Papilloma Virus
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page